Search Results

Tuberculosis, caused by the bacteria Mycobacterium tuberculosis, is a global public health threat. According to the WHO, it is one of the leading killers by a single infectious agent.

A new type of drug could provide a way to treat multidrug-resistant bacteria, according to a study published in Nature Communications.

Six-month regimen expected to improve treatment outcomes; training sessions underway for doctors across Indian states

Tuberculosis (TB) remains one of the world's deadliest infectious diseases, particularly in developing regions

Nationwide initiative aims to equip healthcare professionals with the skills to administer and manage cutting-edge treatment for multi-drug-resistant tuberculosis

The disturbing trend highlights the persistent challenges in eradicating TB, despite having the tools to prevent, detect, and treat it